International Journal of Infertility & Fetal Medicine

Register      Login

VOLUME 3 , ISSUE 3 ( September-December, 2012 ) > List of Articles

RESEARCH ARTICLE

The Correlation between Follicular Fluid Antimullerian Hormone Levels and Fertilization and Embryo Quality in ART Cycles

Rutvij Jay Dalal, Akansha Mishra

Citation Information : Dalal RJ, Mishra A. The Correlation between Follicular Fluid Antimullerian Hormone Levels and Fertilization and Embryo Quality in ART Cycles. Int J Infertil Fetal Med 2012; 3 (3):83-86.

DOI: 10.5005/jp-journals-10016-1047

Published Online: 00-12-2012

Copyright Statement:  Copyright © 2012; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Background

Determination of oocyte and embryo quality are one of the most important goals in in vitro fertilization (IVF). Antimullerian hormone (AMH) is secreted by the ovarian granulosa cells into blood flow and follicular fluid. Follicular fluid (FF) AMH level is probably a marker of activity of granulosa cells.

Objective

To evaluate whether high level of FF AMH level is related to success of fertilization and better embryo quality.

Materials and methods

Sixty-two women, whose FF sample was obtained from a single follicle in each patient, underwent IVF with GnRH-agonist long protocol. Based on oocyte fertilization, the patients were divided into fertilized group (n = 42) and nonfertilized group (n = 20). FF AMH levels were measured in both groups and the quality of embryos was determined in fertilized group.

Results

Median of FF AMH level in fertilized group was higher than that in nonfertilized group (5.7 vs 2.7 ng/ml) and a statistically significant difference was observed between the two groups. There was a significant difference between FF AMH level and scores of embryos (p < 0.001). The medians levels of FF AMH were 6.7 ng/ml in good quality embryos and 3.80 ng/ml in fair quality embryos.

Conclusion

Our results indicate that FF AMH level has positive correlation with fertilization and embryo quality; therefore, it can be considered as a marker of IVF outcome.

How to cite this article

Dalal RJ, Mishra A. The Correlation between Follicular Fluid Antimullerian Hormone Levels and Fertilization and Embryo Quality in ART Cycles. Int J Infertility Fetal Med 2012;3(3):83-86.


PDF Share
  1. Follicular fluid content and oocyte quality: From single biochemical markers to metabolomics. Reprod Biol Endocrinol 2009;7:40.
  2. TGF-{beta} superfamily members and ovarian follicle development. Reproduction 2006;132:191-206.
  3. Antimullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum Reprod Update 2010;16:113-30.
  4. Antimüllerian hormone and its role in ovarian function. Mol Cell Endocrinol 2003;211:85-90.
  5. Antimullerian hormone is increased in follicular fluid from unstimulated ovaries in women with polycystic ovary syndrome. Hum Reprod 2008; 23:2122-26.
  6. Antimullerian hormone (AMH): What do we still need to know? Hum Reprod 2009;24:2264-75.
  7. Antimullerian hormone expression pattern in the human ovary: Potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 2004;10:77-83.
  8. Production of antimullerian hormone: Another homology between Sertoli and granulosa cells. Endocrinology 1984;114:1315-20.
  9. Dynamic assays of inhibin B, antimullerian hormone and estradiol following FSH stimulation and ovarian ultrasonography as predictors of IVF outcome. Hum Reprod 2005;20:3178-83.
  10. High reproducibility of serum antimullerian hormone measurements suggests a multi-staged follicular secretion and strengthens its role in the assessment of ovarian follicular status. Hum Reprod 2005;20:923-27.
  11. Basal level of antimullerian hormone is associated with oocyte quality in stimulated cycles. Hum Reprod 2006;21:2022-26.
  12. Mullerian inhibiting substance levels at the time of hCG administration in IVF cycles predict both ovarian reserve and embryo morphology. Hum Reprod 2006;21:159-63.
  13. Antimullerian hormone: Clinical insights into a promising biomarker of ovarian follicular status. Reprod Biomed Online 2006;12:695-703.
  14. Depletion of ovarian reserve in young women after treatment for cancer in childhood: Detection by antimullerian hormone, inhibin B and ovarian ultrasound. Hum Reprod 2003;18:2368-74.
  15. Male Infertility-current trends in the management of azoospermia and oligoasthenoteratozoospermia In: Rao KA (Ed). The infertility manual (3rd ed). New Delhi: Jaypee Brothers Medical Publishers Pvt Ltd. 2009;179-86.
  16. Pronuclear scoring as a predictor of embryo quality in in vitro fertilization program. Folia Histochem Cytobiol 2007;45(Suppl 1):S85-89.
  17. Antimullerian hormone substance from follicular fluid is positively associated with success in oocyte fertilization during in vitro fertilization. Fertil Steril 2008;89:586-91.
  18. Follicular fluid levels of antimullerian hormone as a predictor of oocyte maturation, fertilization rate, and embryonic development in patients with polycystic ovary syndrome. Fertil Steril 2010;93:2299-2302.
  19. Serum and follicular endocrine profile is different in modified natural cycles than in cycles stimulated with gonadotropin and gonadotropin-releasing hormone antagonist. Fertil Steril 2009;92:2069-71.
  20. Antimullerian hormone concentrations in the follicular fluid of the preovulatory follicle are predictive of the implantation potential of the ensuing embryo obtained by in vitro fertilization. J Clin Endocrinol Metab 2007; 92:1796-1802.
  21. Antimullerian hormone and inhibin B as predictors of pregnancy after treatment by in vitro fertilization/intracytoplasmic sperm injection. Fertil Steril 2008;90:2203-10.
  22. Correlations between antimullerian hormone, inhibin B, and activin A in follicular fluid in IVF/ICSI patients for assessing the maturation and developmental potential of oocytes. Eur J Med Res 2007;12:604-08.
  23. Follicular fluid antimullerian hormone and inhibin B concentrations: Comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles. Fertil Steril 2008;89:860-67.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.